Located adjacent to the Polar Park baseball stadium in Worcester, the planned Left Field Building is a $16-million symbol of the ambitious plans in the city for the life sciences as a catalyst for its ever-evolving development efforts.
As people around the U.S. turned inward over the last year and a half, consumers appear to have found a respite from the onslaught of technology dependence: reading.
President Joe Biden announced plans late Wednesday to nominate Rep. Maria Robinson of Framingham to join his administration in the U.S. Department of Energy.
A 24-acre parcel of land at 149 Hayes Memorial Drive on the Marlborough-Northborough border sold to Toronto realty company Oxford Properties Group for $2.1 million, according to the Middlesex South Registry of Deeds.
Galderma, the world’s largest independent dermatology company headquartered in Lausanne, Switzerland, announced Thursday a co-development and option-to-acquire agreement with Framingham-based medical device firm Sofregen Inc.
Hologic, a Marlborough-based medical technology company focused on women’s health, released findings from its first Hologic Global Women’s Health Index, according to a Tuesday press release.
Marlborough medical device manufacturer Boston Scientific Corp. announced Monday a clinical trial for its TheraSphere cancer treatment successfully met both of its primary endpoints.
Akoya Biosciences, a Marlborough bioscience company, has appointed Dr. Myla Lai-Goldman, who has worked extensively in diagnostics and is the chair and co-founder of GeneCentric Therapeutics Inc. of North Carolina, to its board of directors, according to a Wednesday announcement.